Intrapleural Photodynamic Therapy for Mesothelioma: What Place and Which Future?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25912746.
- Also identified by DOI 10.1016/j.athoracsur.2014.12.077.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the surgical multimodal management of malignant pleural mesothelioma, it seems crucial to proceed with an efficient local adjuvant treatment to kill residual tumor cells. Intrapleural photodynamic therapy has recently emerged as a potential candidate in this goal. In this review, we analyzed and classified 16 articles in which patients with malignant pleural mesothelioma received intrapleural photodynamic therapy after maximal surgical resection. The toxicity, effect on survival, and development of the technique were assessed. After two decades of clinical studies, intrapleural photodynamic therapy after surgical resection became a safe treatment that significantly improved the survival of patients.
Medical subject headings
- Lung Neoplasms
- Mesothelioma
- Photochemotherapy
- Photosensitizing Agents
- Pleural Neoplasms